---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-035999"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2026-08-04T20:15:18+00:00"
generated_at: "2026-08-04T20:18:09.868998+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Oncotelic Therapeutics issues $178,410 convertible note to Pacific Pier Capital with 500,000 commitment shares

## Summary
- Gross principal $178,410; net proceeds ~$150,000 after 12% OID and $7,000 legal fee.
- Note convertible at $0.06/share or 85% of lowest traded price in prior 10 trading days.
- 500,000 commitment shares of common stock issued to Pacific Pier as additional consideration.
- Matures one year from August 3, 2026; 12% interest; 12% original issue discount.
- Prepayment allowed within first six months with three trading days' notice.

## SEC filing metadata
- accession: 0001493152-26-035999
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2026-08-04T20:15:18+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315226035999/0001493152-26-035999-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315226035999/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-035999
- JSON: https://secwatch.observer/filing/0001493152-26-035999.json
- Plain text: https://secwatch.observer/filing/0001493152-26-035999.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.